Advertisement

Topics

Topical JAK Inhibitor Active in Atopic Dermatitis

05:30 EDT 14 Sep 2018 | MedPageToday

(MedPage Today) -- Significant improvement in multiple endpoints after 4 weeks with ruxolitinib cream

Original Article: Topical JAK Inhibitor Active in Atopic Dermatitis

NEXT ARTICLE

More From BioPortfolio on "Topical JAK Inhibitor Active in Atopic Dermatitis"

Advertisement
Quick Search
Advertisement
Advertisement